Home-Based Exercise for Cancer Patients
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial aims to determine if a 16-week exercise program can boost physical activity in Black and Hispanic individuals with early-stage breast, colorectal, or prostate cancer. Participants will engage in supervised exercises with a trainer via Zoom, unsupervised exercises at home, or just stretching exercises. Those diagnosed within the last four weeks, who are overweight, and not currently exercising much might be suitable candidates.
As an unphased trial, participants contribute to valuable research that may enhance exercise programs for cancer patients.
Will I have to stop taking my current medications?
The trial information does not specify whether you need to stop taking your current medications. It's best to discuss this with the trial coordinators or your doctor.
Is there any evidence suggesting that this trial's treatments are likely to be safe?
Research has shown that home-based exercise programs are generally safe for people with cancer. Studies have found that both guided and self-directed exercises at home are well-tolerated. Participants most commonly experience mild muscle soreness. This evidence suggests that aerobic and strength exercises at home are a safe choice for those living with cancer.12345
Why are researchers excited about this trial?
Researchers are excited about these home-based exercise programs for cancer patients because they offer flexibility and accessibility that standard exercise programs often lack. The supervised exercise plan provides virtual guidance from a certified trainer, ensuring that patients receive expert support without needing to travel to a gym or clinic. Meanwhile, the unsupervised plan empowers patients to manage their own exercise routines with weekly telehealth check-ins, promoting self-motivation and autonomy. Both approaches aim to improve cardiovascular and strength outcomes while being adaptable to patients' home environments, potentially making exercise more sustainable and appealing for long-term health benefits.
What evidence suggests that this trial's treatments could be effective for increasing physical activity levels in cancer patients?
This trial will compare different home-based exercise approaches for cancer patients. Research has shown that exercising at home, whether guided or independent, benefits cancer patients. Participants may be assigned to a supervised exercise program, which studies have shown enhances fitness and quality of life, particularly for breast cancer patients. Alternatively, some participants will engage in unsupervised exercise, which is also safe and feasible, with only minor side effects commonly reported. Overall, staying active can help reduce treatment side effects and improve well-being for people with cancer.15678
Who Is on the Research Team?
Christina M Dieli-Conwright, PhD
Principal Investigator
Dana-Farber Cancer Institute
Are You a Good Fit for This Trial?
This trial is for Black and Hispanic adults over 18 with stage I-III breast, colorectal, or prostate cancer who are overweight/obese. They must be starting chemotherapy soon, speak English/Spanish, do less than 90 minutes of exercise per week, and can visit Dana-Farber Cancer Institute for data collection.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants engage in a 16-week home-based exercise intervention, including supervised and unsupervised aerobic and resistance exercises, or stretching exercises.
Follow-up
Participants are monitored for safety and effectiveness after treatment, with assessments of cardiovascular and metabolic health, physical fitness, and quality of life.
What Are the Treatments Tested in This Trial?
Interventions
- Attention Control
- Supervised Home-Based Exercise
- Unsupervised Home-Based Exercise
Find a Clinic Near You
Who Is Running the Clinical Trial?
Dana-Farber Cancer Institute
Lead Sponsor
University of Massachusetts, Boston
Collaborator
National Cancer Institute (NCI)
Collaborator